6-K 1 ea0279398-6k_pingan.htm REPORT OF FOREIGN PRIVATE ISSUER

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2026

 

Commission File Number No. 001-42155

 

Ping An Biomedical Co., Ltd.

(Registrant’s Name)

 

22/F, China United Plaza

1002-1008, Tai Nan West Street

Cheung Sha Wan

Kowloon, Hong Kong

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

 

 

 

 

 

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

 

In connection with an annual general meeting of shareholders (the “Meeting” or “Annual General Meeting”) of Ping An Biomedical Co., Ltd. (the “Company”), an exempted company incorporated under the laws of the Cayman Islands, the Company hereby furnishes the following documents:

 

Exhibits

 

Exhibit No.   Description of Exhibit
99.1   Notice and Proxy Statement of Annual General Meeting of Shareholders
99.2   Form of Proxy Card
99.3   Form of the Second Amended and Restated Memorandum of Association

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  PING AN BIOMEDICAL CO., LTD.
     
Date: March 9, 2026 By: /s/ Pijun Liu
  Name:  Pijun Liu
  Title: Chairman of the Board of Directors

 

2